Uptake and patterns of use of gemcitabine for metastatic pancreatic cancer: a population-based study
{{output}}
Gemcitabine was approved for advanced pancreatic cancer in 1996. We investigated uptake and predictors of its use. We identified 3,231 individuals > 65 years in the SEER-Medicare database with stage IV pancreatic adenocarcinoma, diagnosed between 1998-2005, wh... ...